Registered Attendees

Registered Attendees

Print This Page

Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online before the meeting...these abstracts will be available in the Abstract Book at the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Close Window
Fairmont Hotel Vancouver Floorplan

Fairmont Hotel Vancouver Floorplan

Print This Page



Close Window
NOTES:
This meeting occurs in 2015.
This meeting will be conducted in English.

All programs are subject to change. Check this site for updates.


Download Flyer

Integrating Metabolism and Tumor Biology (J1)

joint with the meeting on PI 3-Kinase Signaling Pathways in Disease (J2)

Scientific Organizers: Ralph J. DeBerardinis, Robert T. Abraham and Eyal Gottlieb


January 13—18, 2015

Fairmont Hotel Vancouver, Vancouver, British Columbia, Canada


Sponsored by Astellas Pharma Inc., Bayer HealthCare Pharmaceuticals, ImmunoGen, Inc., Pfizer Inc., and Takeda Pharmaceutical Company


Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

DEADLINES:
Scholarship Deadline: Sep 24, 2014 [details]
Discounted Abstract Deadline: Sep 24, 2014 [details]
Abstract Deadline: Oct 16, 2014 [details]
Discounted Registration Deadline: Nov 13, 2014 [details]

Submit an Abstract Register Yourself Deadlines and Fees
Deadlines and Fees for 2015-J1 ''Integrating Metabolism and Tumor Biology''
Print This Page

Rates and Deadlines listed below are for the 2015-J1 "Integrating Metabolism and Tumor Biology" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On September 24, 2014 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After September 24, 2014 until October 16, 2014 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
September 24, 2014 n/a
Discounted NON-STUDENT Registration
More details
Before and On November 13, 2014 845.00 USD
(includes 150.00 discount)
Regular NON-STUDENT Registration
More details
After November 13, 2014 995.00 USD
Discounted STUDENT Registration
More details
Before and On November 13, 2014 620.00 USD
(includes 150.00 discount)
Regular STUDENT Registration
More details
After November 13, 2014 770.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will    accept no liability for money loss through bank charges, transfers or currency fluctuations.

Close Window
Apply for a Scholarship



About Discounted Abstract Deadline
About Global Health Travel Award Deadline
About Scholarship Deadline
About Abstract Deadline
About Discounted Registration Deadline

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


TUESDAY, JANUARY 13

16:00—20:00
Arrival and Registration

18:00—20:00
Mixer


WEDNESDAY, JANUARY 14

07:00—08:00
Breakfast

08:00—09:00
Keynote Address (Joint)
Registered attendees can view abstracts starting on 12/13/2014

Lewis C. Cantley, Weill Cornell Medical College, USA
Phosphoinositide Kinases and Cancer Metabolism

09:00—11:15
Oncogenic Control of Metabolism (Joint)
Registered attendees can view abstracts starting on 12/13/2014

Ronald A. DePinho, University of Texas MD Anderson Cancer Center, USA
KRAS in Cancer Cell Metabolism and Tumor Maintenance

John Blenis, Weill Cornell Medical College, USA
mTOR Control of Glutamine Metabolism

David M. Sabatini, Whitehead Institute for Biomedical Research, USA
mTOR and the Cell Biology of Nutrient Sensing

Short Talk(s) Chosen from Abstracts

09:40—10:00
Coffee Break

11:15—13:00
Poster Setup

13:00—22:00
Poster Viewing

11:15—14:30
On Own for Lunch

14:30—16:30
Workshop 1: Career Development in Cancer Metabolism

16:30—17:00
Coffee Available

17:00—19:00
Metabolic Perturbations that Drive Malignancy
Registered attendees can view abstracts starting on 12/13/2014

Matthew G. Vander Heiden, Massachusetts Institute of Technology, USA
Pivotal Role of Glycolytic Regulation in Tumor Cell Biology

William G. Kaelin, Jr., Dana-Farber Cancer Institute, USA
2-Hydroxyglutarate Induces a Reversible State of Malignant Transformation

Binhua P. Zhou, University of Kentucky College of Medicine, USA
Metabolic Facilitators of the Epithelial-Mesenchymal Transition

Short Talk Chosen from Abstracts

17:00—19:00
PI3K Effectors
Registered attendees can view abstracts starting on 12/13/2014

NOTE: Proteins that Bind PI3K Lipid Products: Function in Cancer and Immune Disease.

Alex Toker, Beth Israel Deaconess Medical Center, USA
PI 3-Kinase and Akt at the interface of signaling and metabolism

Yoshinori Fukui, Kyushu University, Japan
Critical Roles of DOCK Family Proteins in Migration and Activation of Leukocytes

Sonja Vermeren, University of Edinburgh, UK
PI3K Regulates Integrin-Dependent Processes by Signaling through ARAP3

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites

19:30—22:00
Poster Session 1


THURSDAY, JANUARY 15

07:00—08:00
Breakfast

08:00—11:00
Mitochondrial Metabolism and Cancer
Registered attendees can view abstracts starting on 12/13/2014

Navdeep S. Chandel, Northwestern University, USA
The Importance of Mitochondrial ROS in Cell Growth and Tumorigenesis

Paul Hwang, National Institutes of Health, USA
Role of TP53 in Regulating Mitochondrial Metabolism

Ralph J. DeBerardinis, University of Texas Southwestern Medical Center, USA
Metabolic Flux in Live Tumors

Short Talk(s) Chosen from Abstracts

08:00—11:00
PI3K/Akt/mTOR in Immune Function, Inflammation
Registered attendees can view abstracts starting on 12/13/2014

Phillip T. Hawkins, Babraham Institute, UK
PI3K Signaling in Neutrophils

Klaus Okkenhaug, Babraham Institute, UK
PI3K in Immunity, Infection and Cancer

David A. Fruman, University of California, Irvine, USA
PI3K/mTOR Inhibitor Action in Lymphocytes

Robert C. Rickert, Sanford-Burnham Medical Research Institute, USA
The PI3K Pathway in B Cell Metabolism

Short Talk(s) Chosen from Abstracts

09:20—09:40
Coffee Break

11:00—13:00
Poster Setup

13:00—22:00
Poster Viewing

11:00—14:30
On Own for Lunch

14:30—16:30
Workshop 2: Novel Targets and Pathways

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—19:15
Model Organisms as Tools to Understand Metabolism, Growth and Cancer
Registered attendees can view abstracts starting on 12/13/2014

Benjamin Tu, University of Texas Southwestern Medical Center, USA
Yeast Metabolic Cycles and the Regulation of Cell Growth

A.J. Marian Walhout, University of Massachusetts Medical School, USA
Systems Biology of Metabolic Networks in C. elegans

Alex Gould, MRC National Institute for Medical Research, UK
Regulation of Growth and Metabolism in Drosophila

Leonard I. Zon, HHMI/Children's Hospital Boston, USA
The Role of Nucleotide Deficiency in the Transcriptional Regulation of Neural Crest Differentiation and Melanoma

Short Talk Chosen from Abstracts

17:00—19:00
PI3K in Cancer
Registered attendees can view abstracts starting on 12/13/2014

Lori Friedman, Genentech, Inc., USA
Sensitivity and Resistance to PI3K Pathway Inhibitors

Vuk Stambolic, Ontario Cancer Institute/University Health Network, Canada
Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress

Jean J. Zhao, Dana-Farber Cancer Institute, USA
PI3K Isoforms in Metabolism and Cancer

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites

19:30—22:00
Poster Session 2


FRIDAY, JANUARY 16

07:00—08:00
Breakfast

08:00—11:00
Targeting Cancer Cell Metabolism
Registered attendees can view abstracts starting on 12/13/2014

Robert T. Abraham, Pfizer Worldwide Research and Development, USA
Glutamine Deprivation Stimulates a Stress-Response Network in Cancer Cells

Katharine Yen, Agios Pharmaceuticals, USA
Targeting Mutant IDH in Cancer

Reuben J. Shaw, The Salk Institute, USA
AMPK Reprogramming of Metabolism

Short Talk(s) Chosen from Abstracts

08:00—11:00
PI3K/Akt/mTOR Clinical Translational - Oncology
Registered attendees can view abstracts starting on 12/13/2014

William R. Sellers, Novartis Institutes for BioMedical Research, USA
PI3K Inhibitors in Cancer

José Baselga, Memorial Sloan-Kettering Cancer Center, USA
PI3k and mTOR Inhibitors in Breast Cancer

Mika Derynck, Genentech, Inc., USA
PI3K, AKT Inhibitors in Cancer Trials

Speaker to be Announced

Short Talk(s) Chosen from Abstracts

09:20—09:40
Coffee Break

11:00—13:00
Poster Setup

13:00—22:00
Poster Viewing

11:00—14:30
On Own for Lunch

14:30—16:30
Workshop 3: Strategies for Discovery of Metabolism: Targeted Drugs

Short Talks Chosen from Abstracts

14:30—16:30
Workshop

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—19:15
Metabolite Control of Gene Expression and Protein Function
Registered attendees can view abstracts starting on 12/13/2014

Craig B. Thompson, Memorial Sloan-Kettering Cancer Center, USA
Metabolic Control of Epigenetics in Cancer

George Q. Daley, HHMI/Children's Hospital Boston, USA
Lin28 as a Regulator of Tumor Cell Metabolism

Eric M. Verdin, University of California, San Francisco, USA
Ketone Bodies, Histone Acetylation, and Oxidative Stress Resistance

Marcia C. Haigis, Harvard Medical School, USA
Post-Translational Modifications and Control of Mitochondrial Metabolism

Short Talk Chosen from Abstracts

17:00—19:00
PI3K/Akt/mTOR Clinical Translational - Inflammation
Registered attendees can view abstracts starting on 12/13/2014

Augustin Amour, GlaxoSmithKline, UK
Choosing Biomarkers for PI3K Inhibition in Inflammation

Speakers to be Announced

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites

19:30—22:00
Poster Session 3


SATURDAY, JANUARY 17

07:00—08:00
Breakfast

08:00—11:00
Metabolic Consequences of Cell Stress
Registered attendees can view abstracts starting on 12/13/2014

Eileen P. White, Rutgers University, USA
Autophagy and Mitochondrial Metabolism in Cancer

Eyal Gottlieb, Cancer Research UK, Beatson Institute, UK
Metabolic Control of Cell Proliferation

Karen H. Vousden, Beatson Institute for Cancer Research, UK
A Contribution of Mutant p53 to Tumor Cell Metabolism

Kun-Liang Guan, University of California, San Diego, USA
Transmission of Metabolic Stress Signals

Short Talk(s) Chosen from Abstracts

08:00—11:00
Class II/III PI3K, Trafficking
Registered attendees can view abstracts starting on 12/13/2014

NOTE: Linking Vps34 Regulation of Trafficking with Other Sessions - Autophagy, Metabolism.

Bart Vanhaesebroeck, UCL Cancer Institute, UK
New Physiological Roles of PI3K Isoforms

Volker Haucke, Leibniz Institut fuer Molekulare Pharmakologie, Germany
Talk Title to be Announced

Sharon A. Tooze, London Research Institute, UK
PI3P Effectors in Autophagy

Gilbert Di Paolo, Columbia University, USA
Phosphoinositide Regulation of Membrane Traffic

Short Talk(s) Chosen from Abstracts

09:20—09:40
Coffee Break

11:00—14:30
On Own for Lunch

14:30—16:30
Workshop: Autophagy (Joint)

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—19:00
Influence of the Metabolic Environment on Cancer Development and Tumor Growth
Registered attendees can view abstracts starting on 12/13/2014

Dafna Bar-Sagi, New York University School of Medicine, USA
RAS-Mediated Acquisition of Nutrients from the Microenvironment

Philipp E. Scherer, University of Texas Southwestern Medical Center, USA
Adipokines and Tumor Progression

Robert J. Gillies, H. Lee Moffitt Cancer Center and Research Institute, USA
Causes and Consequences of Tumor Heterogeneity

Short Talk Chosen from Abstracts

17:00—19:00
PI3K Structure and Regulation
Registered attendees can view abstracts starting on 12/13/2014

NOTE: Insights into Structure of PI3K Enzymes, Inhibitor Binding, and Other Modes of Regulation.

Roger L. Williams, Medical Research Council, UK
Structural Insights into Vps34 Regulation

Speaker to be Announced

Jonathan M. Backer, Albert Einstein College of Medicine, USA
Signaling by PI3Kbeta

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites

20:00—23:00
Entertainment


SUNDAY, JANUARY 18

 
Departure


*Session Chair †Speaker invited, not yet responded.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

Astellas Pharma Inc. Bayer HealthCare Pharmaceuticals
ImmunoGen, Inc. Pfizer Inc.
Takeda Pharmaceutical Company Limited
 

We gratefully acknowledge additional support for this conference from:

CEDARLANE Cell Signaling Technology, Inc.
Seahorse Bioscience, Inc.
 

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



GlaxoSmithKline


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Amanda Deem, Assistant Director of Development, Email: AmandaD@keystonesymposia.org,
Phone:+1 970-262-2668

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676